Evaluation of Porcine Pancreatic Islets Transplanted in the Kidney Capsules of Diabetic Mice Using a Clinically Approved Superparamagnetic Iron Oxide (SPIO) and a 1.5T MR Scanner by Kim, Hoe Suk et al.
Korean J Radiol 11(6), Nov/Dec 2010 673
Evaluation of Porcine Pancreatic Islets
Transplanted in the Kidney Capsules of
Diabetic Mice Using a Clinically Approved
Superparamagnetic Iron Oxide (SPIO) and
a 1.5T MR Scanner
Objective: To evaluate transplanted porcine pancreatic islets in the kidney
capsules of diabetic mice using a clinically approved superparamagnetic iron
oxide (SPIO) and a 1.5T MR scanner. 
Materials and Methods: Various numbers of porcine pancreatic islets labeled
with Resovist, a carboxydextran-coated SPIO, were transplanted into the kidney
capsules of normal mice and imaged with a 3D FIESTA sequence using a 1.5T
clinical MR scanner. Labeled (n = 3) and unlabeled (n = 2) islets were transplant-
ed into the kidney capsules of streptozotocin-induced diabetic mice. Blood glu-
cose levels and MR signal intensities were monitored for 30 days post-transplan-
tation. 
Results: There were no significant differences in viability or insulin secretion
between labeled and unlabeled islets. A strong correlation (r
2 > 0.94) was evident
between the number of transplanted islets and T2 relaxation times quantified by
MRI. Transplantation with labeled or unlabeled islets helped restore normal sus-
tained glucose levels in diabetic mice, and nephrectomies induced the recurrence
of diabetes. The MR signal intensity of labeled pancreatic islets decreased by
80% over 30 days. 
Conclusion: The transplantation of SPIO-labeled porcine islets into the kidney
capsule of diabetic mice allows to restore normal glucose levels, and these islets
can be visualized and quantified using a 1.5T clinical MR scanner.
iabetes is a chronic condition in which daily treatment with exogenous
insulin is often required to maintain normoglycemia. However, because it
is difficult to achieve total physiological control of blood glucose levels,
chronic and degenerative complications occur in many patients. Pancreatic islet
grafting can provide an effective therapy and is a potential cure for human type-1
diabetes (1, 2). However, tracking the transplanted islet cells remains a challenge. 
The kidney is an ideal organ for detecting relatively small changes in islet numbers
and function using MRI, because islets transplanted into the kidney capsule do not
migrate as readily as those that have been transplanted into the liver (3, 4). Porcine
insulin differs from human insulin by only one amino acid residue, and thus, porcine
pancreatic islet xenotransplantation is being actively pursued (5). Research into this
therapeutic strategy has almost reached the clinical trial stage (6). 
MRI of superparamagnetic iron oxide (SPIO)-labeled cells is a useful tool for
studying cell trafficking in vivo (7-12), although it is still a matter of debate whether
the disappearance of spots representing islets on MR scans reflects islet rejection (13-
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D15). Furthermore, SPIO-labeled rat islets in isograft models
were imaged using a 1.5T clinical MR scanner (16). Feridex
(Advanced Magnetics, Cambridge, MA), a dextran-coated
SPIO nanoparticle with a diameter of 70-140 nm, has been
extensively used for this purpose. In this previous study, a
combination of electrophoration and a polycationic
transfection agent, such as poly-L-lysine (PLL), was used to
enhance the labeling efficiency of pancreatic islets by
Feridex. These methods, however, can induce cell death
through damage of the plasma membrane and mitochon-
dria (17). Furthermore, PLL is not approved for clinical use
in humans. 
A carboxydextran-coated SPIO agent, Resovist (Schering
AG, Berlin, Germany), is approved for clinical use as a
liver-imaging agent. However, it has not yet been widely
used as a labeling agent for islet transplantation (18). It is
known that the surface modifications of a nanoparticle can
influence cell-labeling efficiency (6, 7, 16, 18, 19). The
purpose of this study was to demonstrate that porcine islets
can be safely and efficiently labeled with Resovist, a
carboxydextran-coated SPIO, in the absence of transfec-
tion agents, and to monitor transplanted porcine islets in
the kidney capsules of diabetic mice using a 1.5T clinical
MR scanner.
MATERIALS AND METHODS
Islet Isolation
Isolation and purification of porcine pancreatic islets was
performed as previously described (20). Briefly, the
pancreas was distended intraductally using ice-cold
University of Wisconsin (UW) solution containing 0.15%
(w/v) Liberase PI (Roche Biochemicals, Basel,
Switzerland); 1.7 ml of this solution was used per gram of
pancreatic tissue. Distended pancreases were then digested
in a modified Ricordi chamber at 29-30 � C, and the
liberated islets were separated from non-islet tissue using a
continuous UW/OptiPrep density gradient on a Cobe 2991
cell separator (Gambro BCT Inc., Lakewood, CO) (21).
Free-floating islets were then cultured in Medium 199
(GIBCO, Grand Island, NY), which was supplemented with
10% fetal bovine serum at 37 � C. After staining 200-μ L
samples of purified islet suspensions in triplicate with
dithizone, islet yields were calculated. 
Islet Labeling
Islet labeling was performed using a clinically approved
SPIO (Resovist) coated with carboxydextran. The overall
hydrodynamic diameter of the particle was 62 nm (22).
The islets were cultivated in culture medium treated with
Resovist (25, 50, or 100 μ g Fe/mL) for 48 hours in a
humidified 5% CO2 incubator at 37 � C. No transfection
agent was used to label islets with Resovist. For control
purposes, islets isolated from the same porcine pancreas
were cultivated in an identical manner, but without the
addition of Resovist. 
Islet viability after labeling was determined by standard
3-trans-2, 5-diphenyltetrazolium bromide (MTT) assays
(Sigma, St. Louis, MO), and the results are presented as
percentages of labeled versus unlabeled islets.
Islet Iron Contents
To measure the iron content of the pancreatic islets, islets
labeled with Resovist (100 μ g Fe/mL) were washed three
times with phosphate-buffered saline (PBS), resuspended
in 6N HCl, and incubated at 70 � C for 30 minutes. The
iron content of labeled islets was determined using a total
iron reagent kit (Pointe Scientific, Canton, MI). Average
iron content per islet cell was calculated by dividing mean
total iron content by total cell number. It was assumed that
an average pancreatic islet contains 2000 islet cells (15).
Transmission Electron Microscopy
Labeled islets were washed with PBS and then fixed in
2.5% glutaraldehyde in 0.1 M PBS (pH 7.4) for two hours.
Subsequently, islets were treated with 2% osmium tetrox-
ide in 0.1 mM cacodylate buffer for two hours. Islets were
then dehydrated with a graded ethanol series (from 50 to
100% ethanol) in propylene oxide (EM Sciences, Fort
Washington, PA). Samples were embedded in pure Epon
resin for 3 days at 60 � C. Next, ultrathin sections were
prepared using glass knives and a Diatome diamond knife
(Reichert-Jung, Vienna, Austria) on an RMC MTXL
ultramicrotome (Tucson, AZ), stained with lead citrate and
uranyl acetate (both from EM Sciences), and then visual-
ized by transmission electron microscopy (TEM) (JEM-100
CX; Jeol, Tokyo, Japan).
Islet Stimulation
Insulin secretion of labeled and unlabeled islets was
measured after stimulation with glucose and theophylline
(Sigma). Briefly, 10 labeled or unlabeled islets were
incubated in non-agitated Krebs Ringer buffer (KRB)
containing low (3 mM) and high (16.7 mM) concentrations
of glucose or 5 mM concentrations of theophylline for 1
hour at 37 � C. Insulin levels in KRB samples were then
measured using a porcine insulin-specific ELISA (Enzyme-
Linked ImmunoSorbent Assay; DAKO, Carpentaria, CA).
The stimulation index was defined as the ratio of
stimulated to basal insulin secretion (4).
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The recipients of islet transplantation were 10 male
Balb/c nude mice (8-10 weeks old) divided into two
groups: normal (n = 5) and diabetic (n = 5). To transplant
islets, a catheter was inserted into the kidney capsule of
mice under anesthesia. 
To establish a correlation between transplanted islet
numbers and MR signal intensities in normal mice, various
numbers of islets (100, 250, 500, 1000, and 2500) were
transplanted into the kidney capsules of Balb/c nude mice. 
Diabetes was induced in five mice by a single intraperi-
toneal injection of streptozotocin (180 mg/kg). Mice with
blood glucose levels of 300-500 mg/dL for seven consecu-
tive days were considered to be diabetic. Among the five
diabetic mice, 2500 labeled islets were transplanted into
the kidney capsules of each of three diabetic mice, and the
same number of unlabeled islets was transplanted into each
of the remaining two diabetic mice in an identical manner.
Blood Glucose Levels and Glucose Tolerance Tests
To determine the correlation between changes in MR
signal intensity and islet function in diabetic mice, non-
fasting glucose levels were measured in blood from the tail,
every 2-3 days post-transplantation of labeled or
unlabeled islets (SureStep Analyzer; LifeScan, Milpitas,
CA). A fasting blood glucose level was also determined
following the fasting of mice 4 hours prior to the intraperi-
toneal glucose tolerance test (IPGTT). Glucose levels were
measured at 0, 15, 30, and 60 minutes after the glucose
challenge (2 g/kg).
Histological Analysis
To examine the intracellular SPIO distribution in cells,
labeled islets were fixed in 4% paraformaldehyde and
stained with Prussian blue. Briefly, the fixed islets were
washed three times with PBS, and cryosectioned at 4 μ m.
Cryosections were then incubated for 30 minutes with 5%
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AB
Fig. 1. Accumulation of superparamagnetic iron oxide in porcine islets. 
A. Graph shows dose-dependent increase of iron accumulation in islets labeled with Resovist. Islet cells labeled with Resovist (100 μ g
Fe/mL) were found to contain 13.2 ± 3.2 pg of total iron per cell, assuming that pancreatic islets contained 2000 cells on average.
Values are expressed as means ± standard deviations of three independent experiments. Differences were considered significant at p
values ≤ 0.05. *p ≤ 0.05 versus unlabeled. 
B. Prussian blue staining of labeled islets shows intracellular superparamagnetic iron oxide s (blue color) in all labeled islets. Islets were
counterstained with nuclear fast red (red color). 
C. Transmission electron microscopy of labeled islets shows lysosome or endosome containing superparamagnetic iron oxides (arrows).
G = dense granule, ISG = insulin secreting granule, M = mitochondria, N = nucleus
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)potassium ferrocyanide in 5% hydrochloric acid,
rewashed, and counterstained with nuclear fast red for 5
minutes. 
Four weeks after transplantation, kidneys were collected
and fixed in 10% formalin. Prepared paraffin sections 
(4 μ m) were dewaxed, hydrated, and treated with 0.01%
protease XXIV (Sigma) in PBS for 20 minutes at 37 � C.
Insulin was detected using an anti-insulin antibody (Sigma).
Sections were incubated with primary antibodies for 60
minutes, incubated with mouse EnVision polymer
(DakoCytomation, Glostrup, Denmark) for 30 minutes,
and then stained in diaminobenzidine solution
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Fig. 2. Islet viability and insulin secretion. 
A. Viability of labeled and unlabeled islets determined using MTT assays were similar. 
B. Insulin secretion stimulated by treatment with glucose (3 mM or 16.7 mM) and theophylline (5 mM) showed no difference between
labeled and unlabeled islets (p > 0.05). Values are expressed as means ± standard deviations of four independent experiments. 
AB
Fig. 3. In vitro MRI of superparamagnetic iron oxide-labeled porcine pancreatic islets. 
A. Gradient echo T2*-weighted images of 500 islets suspended in 1% agarose phantom show decreased signal intensity of labeled islets
compared to unlabeled islets. 
B. T2 relaxation rates (1/T2) of labeled and unlabeled islets were 12.98 ± 0.01 sec
-1 and 1.002 ± 0.24 sec
-1, respectively (*p = 0.001).
Islets were labeled for 48 hours in medium containing 100 μ g Fe/mL of Resovist.
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Theophylline(DakoCytomation) for 2-5 minutes (all steps performed at
room temperature). The presence of SPIOs within
transplanted islets was detected by Prussian blue staining
and insulin immunostaining, as described above. 
MRI 
To verify the sensitivity of MRI in detecting labeled
islets, in vitro MRI was performed on phantoms containing
500 islets labeled with Resovist (100 μ g of Fe/mL) for 48
hours. To prepare in vitro MR phantoms, labeled and
unlabeled islets were suspended in 1% agarose gel and
transferred to a microtube. MRI of phantoms was
performed using a wrist coil and a 1.5T clinical MR scanner
(Signa Horizon; GE Medical Systems, Milwaukee, WI). The
sequence parameters used were: TR = 5000 ms, TE = 80
ms, FOV = 160 × 160 mm, flip angle = 90� , matrix = 256
× 160, slice thickness/gap = 2.0 mm/0 mm, and NEX =
1.0. T2 relaxation times were measured by conventional
spin-echo (TR/TE = 3300 ms/13, 26, 39, 52, 70, 140, 210,
280, 400, 800, 1200, 1600 ms) with one echo per sequence
while varying TE. T2 relaxation times were calculated by
fitting decreasing signal intensities with increasing TEs into
a mono-exponential function. 
In vivo and ex vivo MRI was performed with a 1.5T
clinical MR scanner using a wrist coil. Mice transplanted
with either labeled or unlabeled islets were scanned using a
gradient echo and 3D FIESTA sequence (FOV = 60×60
mm, TR/TE = 14.8/4.4 ms, flip angle = 45, matrix = 256×
190, slice thickness/gap = 2.0 mm/0 mm, and NEX = 2.0).
Islets transplanted into kidney capsules were imaged
before and at 2, 8, 14, 25, and 30 days after transplanta-
tion. 
T2* relaxation times, related to the different number of
islets transplanted into kidney capsule of normal mice,
were measured similar to the method performed in the
phantom study. Graft volumes of labeled islets
transplanted into the kidney were calculated based on the
graft region of interest (ROI) (4). Ratios of signal intensity
Porcine Pancreatic Islets Transplantation in Renal Capsule and Evaluation Using SPIO-Enhanced MRI
Korean J Radiol 11(6), Nov/Dec 2010 677
A
Fig. 4. MRI quantification of transplanted islets in normal mice. Different numbers (100, 250, 1000, and 2500) of porcine islets were
transplanted into kidney capsules. 
A. Gradient echo T2*-weighted axial images show areas of hypointensity (arrows) in kidney capsules corresponding to different numbers
of transplanted islets. 
B. Graph shows linear correlation (r
2 = 0.9942) between transplanted islet number and graft volume as quantified on gradient echo T2*-
weighted images. 
C. Graph shows linear correlation (r
2 = 0.9356) between islet number and T2* relaxation time as measured on gradient echo T2*-
weighted images.
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C B(SI) to background noise intensity on gradient echo T2*-
weighted images were determined for each kidney, and the
percentage of pre- to post-transplant SI changes were
calculated using the following formula: SI (%) =100 ×
(SIpost-SIpre)/(SIpre). 
For ex vivo MRI, kidneys were fixed in 10% formalin,
and suspended in 3% (wt/vol) gelatin in a styrofoam box.
Ex vivo MRI was also obtained using a 3D FIESTA
sequence. 
Statistical Analysis
Data are expressed as the mean ± standard deviation
(SD). Statistical significance of all data was calculated using
the Mann-Whitney nonparametric test. P values of < 0.05
were considered statistically significant. 
RESULTS
The presence of Resovist in the culture medium
increased cellular iron uptake in islet cells in a dose-
dependent manner (Fig. 1A). Islets labeled with 25 or 100
μ g Fe/mL of Resovist were found to contain 4.80 ± 2.69
pg or 13.2 ± 3.2 pg of total iron per cell, respectively,
assuming that on average, pancreatic islets contained 2000
islet cells. Prussian blue staining indicated efficient iron
accumulation in labeled islets (Fig. 1B), and TEM
demonstrated the presence of SPIOs in the endosomes and
lysosomes of the β -cells (Fig. 1C).
The labeled and unlabeled islets were equally viable (p >
0.05) (Fig. 2A). The stimulation indices of the mean
glucose responsiveness were 1.40 ± 0.24 and 1.41 ± 0.26
for unlabeled and labeled islets, respectively. The stimula-
Kim et al.
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AB
Fig. 5. MRI and blood glucose changes in diabetic mice after transplantation of labeled and unlabeled islets. 
A. Gradient echo T2*-weighted coronal MR images show hypointense area (arrow in left panel) in left kidney containing 2500
transplanted, labeled islets. No signal drop is seen in kidney with unlabeled islets (arrow in right panel). 
B. Graph shows blood glucose levels in diabetic mice measured after labeled or unlabeled islet transplantation. Blood glucose levels in
diabetic mice returned to normal (≤ 150 mg/dL) 24 hours after transplantation and remained normal for 30 days, but nephrectomy
performed at 30 days post-transplantation caused recurrence of elevated blood glucose levels. 
C. Graph shows results of intraperitoneal glucose tolerance tests performed at 28 days post-transplantation. No significant differences
were observed between labeled and unlabeled islets in terms of restoration of normal blood glucose levels. Values are expressed as
mean ± standard deviation.
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0tion indices of theophylline responsiveness in unlabeled
and labeled cells were 4.22 ± 0.84 and 5.15 ± 0.94,
respectively (Fig. 2B). There was no statistically significant
difference in insulin secretion between labeled and
unlabeled islets (p > 0.05).
Labeled islets appeared as hypointense regions on MRI
of phantoms (Fig. 3A). The mean T2 relaxation rates (1/T2)
of labeled and unlabeled islets were 12.98 ± 0.01 sec
-1 and
1.002 ± 0.24 sec
-1, respectively (p = 0.001) (Fig. 3B).
In vivo MRI was performed on normal mice after
transplanting various numbers of islets: 100, 250, 500,
1000, and 2500 (Fig. 4A), with data resulting in a linear
correlation (r
2 = 0.994) between the number of
transplanted islets and graft volume depicted on a gradient
echo T2*-weighted image (Fig. 4B). Furthermore, a linear
correlation was also observed between the number of
transplanted islets and T2* relaxation times measured by a
gradient echo T2*-weighted image (r
2 = 0.936) (Fig. 4C).
Diabetic mice were subjected to in vivo MRI after
transplantation of 2500 labeled or unlabeled islets (Fig.
5A). The blood glucose levels of the diabetic mice returned
to normal (≤ 150 mg/dL) at 24 hours post-transplantation
and remained within normal range for at least 30 days (Fig.
5B). The removal of transplanted islets from diabetic mice
via nephrectomy induced blood glucose levels to increase
by > 150 mg/dL, which are levels considered to be diabetic
(Fig. 5B). To further investigate the function of labeled islet
grafts, we performed an IPGTT analysis at 28 days post-
transplantation in streptozotocin-induced diabetic mice
with glucose levels that had returned to normal. No signifi-
cant difference was observed between the IPGTT glucose
curves of diabetic mice transplanted with labeled and
unlabeled islets (p = 0.47, Fig. 5C).
Figure 6A shows follow-up MR images of
normoglycemic and hyperglycemic mice after transplanta-
tion of labeled islets. At eight days post-transplantation
with labeled islets, blood glucose levels in all three diabetic
mice returned to normal (≤ 150 mg/dL), and the signal
intensity of MR signal decreased approximately 80%
compared with the original signal intensities directly post-
transplantation. However, the blood glucose level of one
of the three diabetic mice increased to a hyperglycemic
level at 25 days post-transplantation. The drop in MR
signal intensity 25 days post-transplantation of labeled
islets in the two normoglycemic mice (120 ± 4.3 mg/dL, n
= 2) and one hyperglycemic mouse (308 mg/dL, n = 1)
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Fig. 6. Correlation between MR signal intensity changes and blood glucose levels in diabetic mice with labeled islets. 
A. Gradient echo T2*-weighted axial images show low signal intensity areas (arrows) in capsules of left kidneys of normoglycemic and
hyperglycemic mouse at 8 and 25 days of post-transplantation. 
B. Blood glucose levels measured 25 days after transplantation of labeled islets in normoglycemic mice (n = 2) and hyperglycemic
mouse (n = 1) were 120 ± 4.3 mg/dL and 308 mg/dL, respectively. 
C. Decreases in MRI signal intensities measured 25 days after transplantation of labeled islets in normoglycemic mice (n = 2) and
hyperglycemic mouse (n = 1) were 81 ± 1.0% and 68%, respectively.
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Ex vivo MRI revealed hypointense areas representing
labeled islets under the capsule of the kidney, which
correlated well with in vivo MRI (Fig. 7A). Histological
studies performed on kidneys at 30 days post-transplanta-
tion with labeled or unlabeled islets demonstrated that
Prussian blue-stained islets were present in the regions that
were hypointense on MRI. Prussian blue-positive islets
were also positive for the production of insulin (Fig. 7B).
DISCUSSION
Porcine islets are a major focus of diabetic research in
the field of nonhuman xenotransplantation. Several in
vitro and in vivo MRI studies have been performed on
SPIO-labeled islets using 9.4T and 4.7T MR scanners (4,
13, 23, 24). In the present study, we monitored SPIO-
labeled porcine islets transplanted in the kidney capsules of
streptozotocin-induced diabetic mice using a 1.5T clinical
MR scanner, and we confirmed the ability of SPIO-labeled
islets to restore normal blood glucose levels. Furthermore,
our findings demonstrate a significant positive correlation
between MR signal intensity and the ability of transplanted
islets to regulate blood glucose levels in diabetic mice. 
Tai et al. (16) also reported that porcine islets labeled
with SPIO could be imaged on a 1.5T clinical MR scanner.
Our study advances the field of knowledge by confirming
the function of transplanted islets in diabetic mice, which
Tai et al. (16) did not demonstrate. These investigators
used a polycationic transfection agent, PLL, to enhance the
labeling efficiency of pancreatic islet cells by Feridex. In
our study, porcine pancreatic islets were labeled with the
carboxydextran-coated SPIO agent, Resovist (100 μ g
Fe/mL) in the absence of PLL, transplanted into streptozo-
tocin-induced diabetic mice, and followed by 1.5T clinical
MR scanner for 30 days. 
First, we confirmed that Resovist is suitable for labeling
porcine pancreatic islets by investigating its effects on islet
function. In a previous study, incubation for 48 hours in a
medium containing Resovist was found to diminish insulin
production (13, 23). However, we found that islets
remained functional after labeling, as determined by in
vitro viability and insulin secretion tests. Because of the
complexity of the pathways involved in glucose-stimulated
insulin secretion, we also tested islet cell insulin secretion
in response to stimulation with theophylline. Glucose
stimulates insulin secretion mainly by increasing the
cytosolic Ca
2+ concentration and by directly promoting
insulin exocytosis (21). Theophylline, a methylxanthine
derivative known to inhibit cyclic nucleotide phosphodi-
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Fig. 7. Ex vivo MRI and histological analysis of diabetic mouse kidneys containing transplanted islets. 
A. Ex vivo MRI of kidneys excised 30 days after transplantation shows labeled pancreatic islets (arrow in upper panel) as hypointense
areas. 
B. Prussian blue staining shows labeled pancreatic islets transplanted into kidney capsule (blue in upper panel). Insulin immunostaining
shows well-preserved transplanted islets (brown in lower panel).
AB
1 cmesterase, increases the intracellular steady state level of
cyclic 3’, 5’-AMP, which results insulin secretion (20).
Thus, data from our study demonstrate that labeling islet
cells with SPIO coated with carboxydextran, does not
inhibit insulin secretion in response to both glucose- and
theophylline-induced stimulation. Significantly, the
transplantation of labeled islets restored glucose levels to a
normal range in diabetic mice. 
In this study, islet cells contained approximately 12 pg of
iron (assuming 2000 cells per islet), which is similar to the
amount in human islet cells labeled with a complex of
Feridex (300 μ g Fe/mL) and PLL, overnight (15). In our
study, the labeling of islet cells using Resovist (25 μ g
Fe/mL) for 48 hours demonstrated increased efficacy over
the combined electrophoresis of the Feridex (25 μ g Fe/mL)
and PLL complex, reported by Tai et al. (16). These
findings are concordant with the results of previous studies
comparing the cell-labeling efficacy of these two SPIO
agents (18, 19). We also found that most iron oxide
particles of Resovist were trapped inside islet cells in
endosomes or lysosomes, which is consistent with previous
reports (15, 16).
We successfully performed MR imaging of Resovist-
labeled pancreatic islet cells in vitro, ex vivo, and in vivo.
Moreover, labeled islets were clearly visualized and
quantified, both in agarose phantoms and in the kidneys of
diabetic mice, as distinct hypointense areas on gradient
echo T2*-weighted images. Evgenov et al. (4)
demonstrated the dependence of T2 relaxation time and
graft volume on the number of transplanted islets by
imaging mice transplanted with varying numbers of islets.
We also demonstrated a significantly positive correlation
of the number of transplanted islet cells with islet volumes
and T2* relaxation times measured by MRI. These results
indicate that this approach could potentially be translated
into clinical practice for measuring graft volume (number)
and for evaluating graft survival. Further studies are
needed to evaluate whether a MRI quantification method
could be used to determine the status of transplanted islets.
MRI quantification is a very useful tool to evaluate
whether a significant number of islets are destroyed or
remain alive in the transplant, regardless of whether the
transplants are allografts, xenografts or isografts (4, 15, 16,
25, 26). Furthermore, in vivo MRI tracking of transplanted
islet cells allows for the detection of a decrease in islet due
to immune rejection or inflammatory response after
transplantation (15, 24). We used the changes in signal
intensity rather than changes in T2 values to monitor
labeled islets in diabetic mice, which could be a limitation. 
Our results suggest that MRI can be utilized to monitor
transplanted islets after labeling with the carboxydextran-
coated SPIO Resovist, without a transfection agent. We
show here that cell labeling with Resovist and tracking by
MRI comprise a useful strategy for detecting small differ-
ences in islet function and islet volume in this murine
diabetic model. The present study provides evidence that
Resovist-labeled islet xenograft restores normal glucose
levels in diabetic mice, and that these islets can be easily
visualized and quantified using a clinically available 1.5T
MR scanner. 
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